Fractional Flow Reserve Market PPT (2021-2026): Global Trends, Scope, Demand, Opportunity and Forecast by 2026

1
Global Fractional Flow Reserve Market Research
and Forecast Report 2021-2026




Author Elena Anderson, Marketing Manager
IMARC Group
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2019 IMARC All Rights Reserved
2
About IMARC Group
Report Description
The International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all sectors
and regions to identify their highest-value
opportunities, address their most critical
challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Fractional Flow Reserve Market Research
Report According to the latest report by IMARC
Group, titled "Fractional Flow Reserve Market
Global Industry Trends, Share, Size, Growth,
Opportunity and Forecast 2021-2026," the global
fractional flow reserve market reached a strong
growth in 2020. Fractional flow reserve (FFR)
refers to an invasive guide wire-based procedure
that is employed to measure the blood pressure
and flow through a specific part of the coronary
artery. It is utilized in coronary
catheterization to calculate the pressure
differences across coronary artery stenosis. Its
usage aids in determining the possibility of the
stenosis impeding the delivery of oxygen to the
heart by analyzing the ratio between the maximum
achievable blood flow in a diseased coronary
artery and the theoretical maximum flow in a
normal coronary artery. It is essential for
assessing if the patient requires angioplasty or
stenting on intermediate blockages. It is widely
recommended by healthcare professionals as this
procedure assists in avoiding unnecessary
surgeries, such as a stent or bypass surgery,
while saving costs. Request Free Sample Report
https//www.imarcgroup.com/fractional-flow-reserve
-market/requestsample
4
Report Description and Highlights
Report Description
Global Fractional Flow Reserve Market Trends
The market is primarily driven by the
increasing incidences of cardiovascular diseases
(CVDs), such as coronary artery diseases and high
blood pressure, across the globe. FFR is
extensively recommended by healthcare
professionals for assessing the possibility of
stenosis that can be responsible for inducible
ischemia. This, in turn, is creating a positive
outlook for the market. There has also been a
significant rise in the occurrence of several
chronic diseases, including type II diabetes.
This can be accredited to the sedentary
lifestyle patterns and increasing consumption of
fast food among the masses. Since type II
diabetes can often lead to the development of
fatty cells in the coronary artery of the
patients and result in blockages, further causing
a stroke or a heart attack, this is, therefore,
expected to catalyze the demand for FFR on the
global level. The market is further driven by the
rising geriatric population as the elderly are
more prone to developing CVDs and diabetes.
Moreover, the increasing number of favorable
clinical outcomes for percutaneous coronary
intervention (PCI) guided by FFR are creating a
positive outlook for the market. This, along with
rising investments in research and development
(RD) activities, is contributing to the market
growth further. Looking forward, the market
value is projected to reach a strong growth
during the forecast period (2021-2026).

5
Report Description and Highlights
Report Description

• Market Summary
• Breakup by Product
• FFR Guidewires
• FFR Monitoring Systems
•  
• Breakup by Application
• Multi-Vessel Coronary Artery Disease
• Single-Vessel Coronary Artery Disease
• Breakup by End User
• Hospitals and Ambulatory Surgery Centers
• Diagnostic Centers
• Others

6
Report Description and Highlights
Report Description

• Breakup by Region
• North America
• United States
• Canada
• Asia Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia

7
Report Description and Highlights
Report Description

• Latin America
• Brazil
• Mexico
• Argentina
• Columbia
• Chile
• Peru
• Others
• Middle East and Africa Turkey
• Saudi Arabia
• Iran
• United Arab Emirates
• Others
• Note We are updating our reports, If you want
  latest primary and secondary data (2021-2026)
  with Cost Module, Business Strategy, Distribution
  Channel, etc. Click request free sample report.

8
Report Description and Highlights
Report Description

• Competitive Landscape with Key Players
• Abbott Laboratories
• ACIST Medical Systems Inc. (Bracco S.p.A.)
• Boston Scientific Corporation
• CathWorks Ltd.
• Heartflow Inc.
• Koninklijke Philips N.V.
• Medis Medical Imaging Systems B.V.
• Opsens Inc.
• Pie Medical Imaging B.V. (Esaote Group)
• Siemens Healthineers AG
• Terumo Medical Corporation.
• View Full Report with TOC List of Figure
  https//www.imarcgroup.com/fractional-flow-reserve
  -market

9
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
10
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
11
Report Description and Highlights
Report Description

2019 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
12

Contact Us